| 期 |
栏目 |
标题 |
文件 |
| 卷 90, 编号 8 (2018) |
Editorial |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
High resolution manometry and new classification of esophageal motility disorders |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program “odyssey” |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
Features of the functional activity of macrophage link of immunity with gastroesophageal reflux disease depending on the type of reluctate: in vitro model |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
The cardiovascular system in patients with functional and inflammatory bowel diseases |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications |
(Rus)
|
| 卷 92, 编号 1 (2020) |
Editorial |
The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study |
(Rus)
|
| 卷 92, 编号 2 (2020) |
Editorial |
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C |
(Rus)
|
| 卷 92, 编号 8 (2020) |
Editorial |
Novel coronavirus infection COVID-19: extrapulmonary manifestations |
(Rus)
|
| 卷 92, 编号 8 (2020) |
Original articles |
Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results |
(Rus)
|
| 卷 92, 编号 11 (2020) |
Original articles |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
(Rus)
|
| 卷 92, 编号 12 (2020) |
Articles |
The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis |
(Rus)
|
| 卷 92, 编号 12 (2020) |
Articles |
Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis |
(Rus)
|
| 卷 92, 编号 12 (2020) |
Articles |
Rebamipide: evidence base for use in gastroenterology |
(Rus)
|
| 卷 92, 编号 12 (2020) |
Articles |
Recommendations for the Protocol of functional examination of the anorectal zone and disorders classification: the International Anorectal Physiology Working Group consensus and Russian real-world practice |
(Rus)
|
| 卷 93, 编号 2 (2021) |
Original articles |
Efficacy of butyric acid inclusion in eradication regimens for Helicobacter pylori infection: a meta-analysis of controlled trials |
(Rus)
|
| 卷 93, 编号 4 (2021) |
Reviews |
Exocrine pancreas insufficiency: clinical significance and approaches to correction from evidence medicine |
(Rus)
|
| 卷 93, 编号 8 (2021) |
Original articles |
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic |
(Rus)
|
| 卷 93, 编号 8 (2021) |
Reviews |
Obesity as a risk factor for diseases of the digestive system |
(Rus)
|
| 卷 93, 编号 12 (2021) |
Original articles |
Complex assessment of esophageal acidification and motor function in patients with Barrett's esophagus on antisecretory therapy |
(Rus)
|
| 卷 94, 编号 2 (2022) |
Original articles |
The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus |
(Rus)
|
| 卷 94, 编号 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
| 卷 94, 编号 8 (2022) |
Original articles |
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Original articles |
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria |
(Rus)
|
| 卷 94, 编号 10 (2022) |
Original articles |
Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 |
(Rus)
|
| 卷 94, 编号 12 (2022) |
Original articles |
Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials |
(Rus)
|
| 卷 95, 编号 1 (2023) |
Original articles |
Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study |
(Rus)
|
| 卷 95, 编号 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
| 卷 95, 编号 2 (2023) |
Original articles |
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity |
(Rus)
|
| 卷 95, 编号 8 (2023) |
Reviews |
Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review |
(Rus)
|
| 卷 95, 编号 12 (2023) |
Editorial |
Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients |
(Rus)
|
